Omics‐based profiling of carcinoma of the breast and matched regional lymph node metastasis

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Proteomics

• Publication date

  2008-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/pmic.200800303PMID 19003862
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Direct evidence for epithelial-mesenchymal transitions in breast cancer.

  2008cited by this paper
• Breast cancer metastases are molecularly distinct from their primary tumors

  2008cited by this paper
• Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients

  2007cited by this paper
• Gene expression profiling of human lymph node metastases and matched primary breast carcinomas: Clinical implications

  2007cited by this paper
• Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progression

  2007cited by this paper
• Is metastasis predetermined?

  2007cited by this paper
• Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia

  2007cited by this paper
• Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation

  2006cited by this paper
• Prognostic value of nodal ratios in node-positive breast cancer.

  2006cited by this paper
• A comparison study: applying segmentation to array CGH data for downstream analyses

  2005cited by this paper
• No common denominator for breast cancer lymph node metastasis

  2005influential reference
• High-resolution mapping of genotype-phenotype relationships in cri du chat syndrome using array comparative genomic hybridization.

  2005cited by this paper
• DNA index and cell cycle analysis of primary breast cancer and synchronous axillary lymph node metastases

  2005cited by this paper
• Down-regulation of the Tumor Suppressor Protein 14-3-3σ Is a Sporadic Event in Cancer of the Breast

  2005cited by this paper
• Molecular requirements for epithelial-mesenchymal transition during tumor progression.

  2005cited by this paper
• Identification of Extracellular and Intracellular Signaling Components of the Mammary Adipose Tissue and Its Interstitial Fluid in High Risk Breast Cancer Patients

  2005influential reference
• Towards discovery‐driven translational research in breast cancer

  2004cited by this paper
• Distinguishing key biological pathways between primary breast cancers and their lymph node metastases by gene function-based clustering analysis.

  2004cited by this paper
• Open source clustering software.

  2004cited by this paper
• Expression of the Tumor Suppressor Protein 14-3-3σ Is Down-regulated in Invasive Transitional Cell Carcinomas of the Urinary Bladder Undergoing Epithelial-to-Mesenchymal Transition*

  2004cited by this paper
• Proteomic Characterization of the Interstitial Fluid Perfusing the Breast Tumor Microenvironment

  2004cited by this paper
• Circular binary segmentation for the analysis of array-based DNA copy number data.

  2004cited by this paper
• Patients with Recurrent Breast Cancer: Does the Primary Axillary Lymph node Status Predict more Aggressive Tumor Progression?

  2003cited by this paper
• Chromosome aberrations in solid tumors

  2003cited by this paper
• Association of C‐MYC amplification with progression from the in situ to the invasive stage in C‐MYC‐amplified breast carcinomas

  2003cited by this paper
• Allelic diversity in the host genetic background may be an important determinant in tumor metastatic dissemination.

  2003cited by this paper
• Integrating Proteomic and Functional Genomic Technologies in Discovery-driven Translational Breast Cancer Research*

  2003cited by this paper
• Genetic background is an important determinant of metastatic potential

  2003cited by this paper
• Gene expression profiles of primary breast tumors maintained in distant metastases

  2003cited by this paper
• Compilation of published comparative genomic hybridization studies.

  2002influential reference
• Metastasis: Lymphangiogenesis and cancer metastasis

  2002cited by this paper
• A progression puzzle.

  2002cited by this paper
• Prognostic Factors in Node-Negative Breast Cancer: A Review of Studies With Sample Size More Than 200 and Follow-Up More Than 5 Years

  2002cited by this paper
• Lymphatic function, lymphangiogenesis, and cancer metastasis

  2001cited by this paper
• High-resolution two-dimensional gel electrophoresis and protein identification using western blotting and ECL detection.

  2000cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• Psoriasin (S100A7): A putative urinary marker for the follow‐up of patients with bladder squamous cell carcinomas

  1999cited by this paper
• Cytokeratins as markers of differentiation in the diagnosis of epithelial tumors.

  1998cited by this paper
• Cell Biology: A Laboratory Handbook

  1997cited by this paper
• Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups.

  1997cited by this paper
• p53 tumor‐suppressor gene: Clues to molecular carcinogenesis

  1997cited by this paper
• Genetic alterations in primary breast cancers and their metastases: Direct comparison using modified comparative genomic hybridization

  1997cited by this paper
• Axillary lymphadenectomy for breast cancer. Paradigm shifts and pragmatic surgeons.

  1996cited by this paper
• Proteins of the Myc network: essential regulators of cell growth and differentiation.

  1996cited by this paper
• Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels.

  1996cited by this paper
• Karnofsky Memorial Lecture. Natural history of small breast cancers.

  1994cited by this paper
• Tumor labeling indices of primary breast cancers and their regional lymph node metastases

  1993cited by this paper
• Proliferative activity of primary breast cancer and of synchronous lymph node metastases evaluated by [3H]‐thymidine labelling index

  1990cited by this paper
• A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma.

  1989cited by this paper
• Breast cancer in the medial half. Results of 1978 national survey of the American College of surgeons

  1983cited by this paper
• The pathogenesis of cancer metastasis

  1980cited by this paper
• Metastasis results from preexisting variant cells within a malignant tumor.

  1977cited by this paper
• The clonal evolution of tumor cell populations.

  1976cited by this paper
• High resolution two-dimensional electrophoresis of proteins.

  1975influential reference

• Proteomics of REPLICANT perfusate detects changes in the metastatic lymph node microenvironment

  2021cites this paper
• Proteomics of REPLICANT perfusate detects changes in the metastatic lymph node microenvironment

  2021cites this paper
• Predictive factors of non-sentinel axillary lymph nodes in breast cancer patients . Molecular markers of primary tumor and variability of patient ' s microenvironment

  2017cites this paper
• Elucidation of a Conserved Proteomic Pattern of Breast Cancer Tissue and Metastatic Axillary Lymph Node.

  2017cites this paper
• Molecular Concordance Between Primary Breast Cancer and Matched Metastases

  2016cites this paper
• Clonal expansion and linear genome evolution through breast cancer progression from pre-invasive stages to asynchronous metastasis

  2015cites this paper
• Changes in glycoprotein expression between primary breast tumour and synchronous lymph node metastases or asynchronous distant metastases

  2015cites this paper
• Comparative proteomics of primary breast carcinomas and lymph node metastases outlining markers of tumor invasion.

  2015cites this paper
• Increased copy number of the DLX4 homeobox gene in breast axillary lymph node metastasis.

  2014cites this paper
• Proteomic analysis of tissue samples in translational breast cancer research

  2014cites this paper
• Pathway-Centric Integrative Analysis Identifies RRM2 as a Prognostic Marker in Breast Cancer Associated with Poor Survival and Tamoxifen Resistance123

  2014cites this paper
• Expression of the Epidermal Growth Factor Receptors and Ligands in Paired Samples of Normal Breast Tissue, Primary Breast Carcinomas and Lymph Node Metastases

  2014cites this paper
• Omics of Male Breast Cancer

  2014cites this paper
• Pathway-Centric Integrative Analysis Identifies RRM2 as a Prognostic Marker in Breast Cancer Associated with Poor Survival and

  2014cites this paper
• A PRELIMINARY STUDY: COMPARATIVE PROTEOMIC PROFILING OF BREAST CANCER TISSUE AND METASTATIC AXILLARY LYMPH NODE

  2013cites this paper
• Biological resonance for cancer metastasis, a new hypothesis based on comparisons between primary cancers and metastases

  2013cites this paper
• A PRELIMINARY STUDY: COMPARATIVE PROTEOMIC PROFILING OF BREAST CANCER TISSUE AND METASTATIC AXILLARY LYMPH NODE BİR ÖN ÇALIŞMA: MEME KANSERİ DOKUSUNUN VE AKSİLLER METASTATİK LENF NODUNUN PROTEOMİK PROFİLLENMESİ

  2013cites this paper
• Genomic analysis: toward a new approach in breast cancer management.

  2012cites this paper
• Differential proteomic analysis of a human breast tumor and its matched bone metastasis identifies cell membrane and extracellular proteins associated with bone metastasis.

  2012cites this paper
• Array comparative genomic hybridization of keratoacanthomas and squamous cell carcinomas: different patterns of genetic aberrations suggest two distinct entities.

  2012cites this paper
• Integrated analysis of copy number and loss of heterozygosity in primary breast carcinomas using high-density SNP array.

  2011cites this paper
• Meta-data analysis as a strategy to evaluate individual and common features of proteomic changes in breast cancer.

  2011cites this paper
• Molecular Signatures of Bladder Cancer

  2011cites this paper
• Differential protein expression in primary breast cancer and matched axillary node metastasis.

  2011cites this paper
• Tumor heterogeneity in neoplasms of breast, colon, and skin

  2010cites this paper
• Clinical Application of Proteomics in Breast Cancer: State of the Art and Perspectives

  2010cites this paper
• Variations in stromal signatures in breast and colorectal cancer metastases

  2010cites this paper
• Frequent genetic differences between matched primary and metastatic breast cancer provide an approach to identification of biomarkers for disease progression

  2010cites this paper
• A PROTEOMIC ANALYSIS OF NEOPLASTIC PROGRESSION IN BREAST CANCER

  2010cites this paper
• Molecular markers of breast axillary lymph node metastasis

  2009cites this paper
• DNA Copy Number Aberrations in Breast Cancer by Array Comparative Genomic Hybridization

  2009cites this paper
• Estimation of tumor heterogeneity using CGH array data

  2009cites this paper
• A single lysis solution for the analysis of tissue samples by different proteomic technologies

  2008cites this paper